Frontlight ResearchEarly access
Trial site
Shenjing Hospital of China Medical University
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Deep vein thrombosis and pulmonary embolism2 trials
- Immune thrombocytopenia (ITP)2 trials
- Lupus (SLE)1 trial
- Phase
- Phase 22 trials
- Phase 2/31 trial
- Phase 31 trial
- Status
- Not yet recruiting3 trials
- Recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.3 trials
- Shengjing Hospital2 trials
- Vertex Pharmaceuticals Incorporated1 trial
Running trials
Recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)
Recruiting
A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.
Active, not recruiting
An Observational Study About Adverse Outcomes in Acute Pulmonary Embolism Patients
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Immune thrombocytopenia (ITP)2 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Lupus (SLE)1 recruiting
Site data: ClinicalTrials.govUpdated 19 Nov 2026